Evoke Pharma Inc (EVOK) Directors and Executive Officers

Officers & Directors

Todd C. Brady, M.D., Ph.D.
Director

David A. Gonyer, R.Ph.
Chief Executive Officer and Director (principal executive officer)

Cam L. Garner
Chairman of the Board of Directors

Kenneth J. Widder, M.D.
Director

Matthew J. D Onofrio
President, Chief Operating Officer, Treasurer

Vickie W. Reed
Director

Malcolm R. Hill, Pharm. D.
Director

BDO USA, P.C.
Company Auditor ,

Evoke Pharma Inc currently has 8 employees.

News about Evoke Pharma Inc Key Personnel

Evoke Pharmas Strategic Moves: Pioneering Gastroparesis Solutions Amid Market Transitions and Shareholder Enhancements

In the ever-evolving landscape of pharmaceutical innovation, Evoke Pharma, Inc. (NASDAQ: EVOK) is carving out a significant niche as a leading provider of treatments for gastrointestinal (GI...

Evoke Pharma: Seizing Opportunities to Revolutionize GI Therapeutics with Recent Underwritten Public Offering

Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company specializing in gastrointestinal (GI) disease treatments, has recently disclosed the pricing details of its underwritten public offering. The company aims to raise gross proceeds of up to $30 million through this offering, with an initial upfront funding of approximately $7.5 million. The offering is being led by Nantahala Capital Management, along with the participation of other fundamental investors. This substantial funding will further support Evoke Pharma s development and commercialization plans for its key product, GIMOTI (metoclopramide) na...